Plasma catecholamine responses children adolescents IDDM OBJECTIVE goal study children adolescents insulin-dependent diabetes IDDM catecholamine responses insulin-induced hypoglycemia adults pathogenesis decreased response terms possible relationships neuropathy hyperinsulinism RESEARCH DESIGN AND METHODS before-and-after trial effects days intensive insulin therapy subjects IDDM age yr duration diabetes yr control group children non-growth hormone-deficient short stature age yr Hypoglycemia intravenous insulin bolus U/kg insulin withdrawal days intensive insulin therapy diabetic subjects inpatient basis role hyperinsulinism catecholamine response hypoglycemia Control insulin bolus microU/kg Autonomic neuropathy computerized assessment basal R-R variation inspiration expiration pancreatic polypeptide response hypoglycemia RESULTS Basal catecholamine levels diabetic subjects intensive insulin therapy control subjects peak incremental catecholamine responses insulin withdrawal intensive insulin therapy IDDM subjects control subjects Peak catecholamine responses IDDM intensive insulin therapy true plasma nadir levels mmol diminished catecholamine responses due decreased peak epinephrine responses intensive insulin therapy insulin withdrawal significant correlations catecholamine response hypoglycemia age duration diabetes pancreatic polypeptide R-R interval CONCLUSIONS results children adolescents IDDM insulin withdrawal catecholamine response hypoglycemia control subjects short-term intensive insulin therapy response hyperinsulinism role catecholamine response hypoglycemia evidence clinical subclinical role autonomic neuropathy altered catecholamine responses 